MBP and myeloid sarcoma: There exist data to suggest that circulating anti-myelin basic protein (MBP) antibodies isolated from the sera of individuals living with MS can act as hydrolyzing enzymes against histone proteins with high rates of H1 cleavage activity to damage nuclei of cells [77].